CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The CXCR3 ligand CXCL9 attenuates neoangiogenesis and liver fibrosis in vivo
DOI 10.1055/s-0031-1295777
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Sahin, P Schmitz, F Kiessling, C Trautwein, HE Wasmuth
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Recently, we could show that CXCR3-/- mice display exaggerated liver fibrosis compared to wild-type littermates after chronic CCl4 treatment (Wasmuth et al. Gastroenterology 2009). Notably, CXCL9, the ligand of CXCR3, has also angiostatic effects. The aims of this project were to quantify angiogenesis in CXCR3-/- and wild-type mice after CCl4 treatment and to study the feasibility of modulating liver fibrosis…
Zitieren
Zitierempfehlung
H Sahin, P Schmitz, F Kiessling, C Trautwein, HE Wasmuth (2012) The CXCR3 ligand CXCL9 attenuates neoangiogenesis and liver fibrosis in vivo. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295777
Mit CareLit weiterarbeiten